PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Publications
Contact Us
Log In
You need to enable JavaScript to run this app page.
Pancreas
BCM-PDAC-10
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-PDAC-10
Contact Model Developer
Model Contact
Model: BCM-PDAC-10
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email:
qizhiyao@bcm.edu
Patient Information
Clinical Timeline
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-PDAC-10
Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 272
F
P
1
2
3
4
5
6
7
8
9
10
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AKAP9
chr7
92001075
92001075
A
T
c.1158A>T
aaA/aaT
p.K386N
0.485
8
2
Missense Variant
Missense Variant
MODERATE
ENST00000356239.8
Conflicting_interpretations_of_pathogenicity
0.000153447000
rs142673316
8
2
ENST00000356239.8
Conflicting_interpretations_of_pathogenicity
rs142673316
AKAP9
chr7
92085597
92085597
C
T
c.8935C>T
Cct/Tct
p.P2979S
0.992
8
8
Missense Variant
Missense Variant
MODERATE
ENST00000356239.8
Benign/Likely_benign
COSV104663065
0.996325000000
rs1063242
8
8
ENST00000356239.8
Benign/Likely_benign
COSV104663065
rs1063242
ALK
chr2
29193500
29193500
G
C
c.4587C>G
gaC/gaG
p.D1529E
0.502
8
7
Missense Variant
Missense Variant
MODERATE
ENST00000389048.8
Benign
COSV66569695
0.472160000000
rs1881421
8
7
ENST00000389048.8
Benign
COSV66569695
rs1881421
ALK
chr2
29193706
29193706
T
C
c.4381A>G
Atc/Gtc
p.I1461V
0.995
8
8
Missense Variant
Missense Variant
MODERATE
ENST00000389048.8
Benign
COSV101201052
0.997594000000
rs1670283
8
8
ENST00000389048.8
Benign
COSV101201052
rs1670283
ALK
chr2
29193615
29193615
T
C
c.4472A>G
aAg/aGg
p.K1491R
0.497
8
7
Missense Variant
Missense Variant
MODERATE
ENST00000389048.8
Benign
COSV66555753
0.349007000000
rs1881420
8
7
ENST00000389048.8
Benign
COSV66555753
rs1881420
ANK1
chr8
41690485
41690485
T
C
c.3973A>G
Atg/Gtg
p.M1325V
0.497
5
3
Missense Variant
Missense Variant
MODERATE
ENST00000289734.13
Benign
0.013245000000
rs10093583
5
3
ENST00000289734.13
Benign
rs10093583
ANK1
chr8
41724513
41724513
G
T
c.654C>A
aaC/aaA
p.N218K
0.048
5
3
Missense Variant
Missense Variant
MODERATE
ENST00000289734.13
Benign/Likely_benign
0.011266600000
rs61735313
5
3
ENST00000289734.13
Benign/Likely_benign
rs61735313
ANK1
chr8
41708920
41708920
C
T
c.1856G>A
cGt/cAt
p.R619H
0.497
5
3
Missense Variant
Missense Variant
MODERATE
ENST00000289734.13
Benign/Likely_benign
COSV55882618
0.044445800000
rs2304877
5
3
ENST00000289734.13
Benign/Likely_benign
COSV55882618
rs2304877
APC
chr5
112841059
112841059
T
A
c.5465T>A
gTc/gAc
p.V1822D
0.954
7
7
Missense Variant
Missense Variant
MODERATE
ENST00000257430.9
Benign
COSV57321643
0.794920000000
rs459552
7
7
ENST00000257430.9
Benign
COSV57321643
rs459552
APOBEC3B
chr22
38989518
38989518
C
T
c.631C>T
Cgg/Tgg
p.R211W
0.329
3
3
Missense Variant
Missense Variant
MODERATE
ENST00000333467.4
Likely_benign
COSV59841187
0.000312383000
rs200770515
3
3
ENST00000333467.4
Likely_benign
COSV59841187
rs200770515
ARHGEF10
chr8
1909425
1909425
G
A
c.2098G>A
Gtt/Att
p.V700I
0.528
3
2
Missense Variant
Missense Variant
MODERATE
ENST00000349830.8
Benign
COSV50643436
0.031365600000
rs2294039
3
2
ENST00000349830.8
Benign
COSV50643436
rs2294039
ARID1A
chr1
26779439
26779439
T
TG
c.5548dup
-/G
p.D1850Gfs*4
0.567
6
2
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000324856.13
COSV61371153
rs758608743
6
2
ENST00000324856.13
COSV61371153
rs758608743
ARID1B
chr6
156778366
156778366
G
A
c.686G>A
gGc/gAc
p.G229D
0.222
6
1
Missense Variant
Missense Variant
MODERATE
ENST00000636930.2
rs1208360824
6
1
ENST00000636930.2
rs1208360824
ARID1B
chr6
156779262
156779262
G
GCGC
c.1597_1599dup
gcg/gCGCcg
p.P533dup
0.356
6
3
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000636930.2
COSV51649563
.
6
3
ENST00000636930.2
COSV51649563
.
ATM
chr11
108254034
108254034
T
C
c.2119T>C
Tct/Cct
p.S707P
0.485
6
2
Missense Variant
Missense Variant
MODERATE
ENST00000278616.8
Benign/Likely_benign
COSV53743430
0.007819920000
rs4986761
6
2
ENST00000278616.8
Benign/Likely_benign
COSV53743430
rs4986761
Total mutations showing: 272
F
P
1
2
3
4
5
6
7
8
9
10
N
E
Rows Per Page
10
15
25
50
Download
CNV
Histology Information for Model: BCM-PDAC-10
There are no histology images for this model.
Metastasis Information for Model: BCM-PDAC-10
Patient
PDX
Liver
Local
Local recurrence
Lung
Rectum
lymph node
Patient Treatment Information for Model: BCM-PDAC-10
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
5
Folfirinox
Neoadjuvant
58.23
58.33
37 days
Partial Response (PR)
Partial Response (pPR); score 2
Side Effects
Please wait...